No definition available.
Follicular adenocarcinoma of thyroid gland, including Hilmo
C3_THYROID_FOLLICULAR_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
400 |
4. Check minimum number of eventsNone |
400 |
5. Include endpointsNone |
400 |
6. Filter based on genotype QC (FinnGen only) |
387 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Follicular adenocarcinoma of thyroid gland, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland, including Hilmo
- Malignant neoplasm of endocrine gland, including Hilmo
- Disorders of the thyroid gland
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 387 | 256 | 131 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 54.36 | 51.20 | 60.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 400
- Matched controls
- 4000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
307.7
367
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
57.7
307.7
207
73
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
126.8
307.7
199
31
104
Kela drug reimbursment
Thyroid insufficiency
65.4
307.7
290
155
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
279.0
234
*
H03AA01
ATC
levothyroxine sodium; systemic
129.9
278.0
385
660
BAA60
NOMESCO Finland
Total thyroidectomy
64.6
238.9
137
32
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
67.7
223.2
126
27
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
490.1
183.6
170
6
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
175.3
155
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
331.5
168.6
160
8
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
137.7
124
*
ZX114
NOMESCO Finland
Intramuscular
62.5
127.9
72
14
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
46.5
105.1
63
16
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
25.9
80.7
58
26
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
14.0
80.0
80
70
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
67.7
63
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.8
66.9
252
908
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
65.4
61
*
130
Kela drug reimbursment
Malignant tumour
+∞
64.3
60
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
63.2
59
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
25.3
57.0
41
18
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
56.6
53
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
16.4
54.5
48
33
H02AB02
ATC
dexamethasone; systemic
24.6
52.4
38
17
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
51.2
48
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.4
47.9
203
756
4CJ01, ,
NOMESCO Finland
+∞
46.8
44
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
42.5
40
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.9
37.4
55
79
WX402
NOMESCO Finland
General anaesthesia
4.0
35.1
131
430
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
34.9
33
*
Z51.88
ICD-10 Finland
Other specified medical care
10.9
32.3
36
36
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
31.7
30
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
173.4
31.2
32
*
JN4AD
NOMESCO Finland
Body CT examination
6.3
29.7
54
97
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
29.5
28
*
115
Kela drug reimbursment
Breast cancer
+∞
29.5
28
*
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
69.3
28.4
32
5
WW200
NOMESCO Finland
Immunization
10.4
27.1
31
32
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
26.3
25
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
25.3
24
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.3
24
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
92.5
24.0
26
*
Z51.5
ICD-10 Finland
Palliative care
6.8
23.6
39
63
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
23.1
22
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
48.0
22.7
27
6
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
22.1
21
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
22.1
21
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
22.1
21
*
A04AA02
ATC
granisetron; systemic, transdermal
232.2
21.8
22
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
232.2
21.8
22
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
18.8
21.7
33
19
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
21.0
177
901
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
116.1
20.8
22
*
WF002
NOMESCO Finland
Radical radiotherapy
60.8
20.1
23
*
JN4BD
NOMESCO Finland
Extensive body CT
5.8
19.9
38
71
WZC30
NOMESCO Finland
Teaching
3.5
19.5
78
260
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
18.9
18
*
T71
ICPC
Malignant neoplasm thyroid
+∞
18.9
18
*
JN6AD
NOMESCO Finland
CT of torso and neck
31.8
18.5
24
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
18.0
101
411
106
Kela drug reimbursment
Hypoparathyroidism
99.5
17.7
19
*
HA1AA
NOMESCO Finland
X-ray mammography
5.8
16.9
32
59
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
66.3
16.9
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.8
16.9
27
42
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
16.8
119
545
GD1AD
NOMESCO Finland
Thorax CT examination
5.0
16.7
38
83
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
177.1
16.6
17
*
A11CC03
ATC
alfacalcidol; systemic
12.4
16.3
29
25
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
14.7
14
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
14.7
14
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
14.5
31
64
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
14.4
81
327
N02AA05
ATC
oxycodone; systemic
2.8
14.2
82
335
GD6AD
NOMESCO Finland
CT of chest and neck
44.2
14.2
17
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
55.4
13.9
16
*
JN5SN, ,
NOMESCO Finland
+∞
13.6
13
*
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
13.6
13
*
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
13.6
13
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
26.8
13.5
18
7
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
23.5
13.0
18
8
NK6AN
NOMESCO Finland
Total body bone isotope imaging
51.8
12.9
15
*
L02BG04
ATC
letrozole; oral
9.8
12.7
25
27
198
Kela drug reimbursment
Sorafenib
+∞
12.6
12
*
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
12.6
12
*
323
Kela drug reimbursment
Sorafenib
+∞
12.6
12
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
134.0
12.5
13
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
134.0
12.5
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.9
12.3
15
*
WX704
NOMESCO Finland
Intubation
3.6
11.7
40
119
L03AA13
ATC
pegfilgrastim; parenteral
67.0
11.7
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.7
11.1
26
58
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
10.8
199
1314
L02BA01
ATC
tamoxifen; oral
61.7
10.7
12
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.7
10.6
25
56
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
10.6
94
468
Z31.5
ICD-10 Finland
Genetic counselling
4.4
10.5
27
65
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
112.9
10.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
112.9
10.5
11
*
3019
Kela drug reimbursment
Lenvatinib
+∞
10.5
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.5
10
*
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
10.5
10
*
2506
FHL
Thyroidectomy
+∞
10.5
10
*
1508
Kela drug reimbursment
Lenvatinib
+∞
10.5
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.2
10.0
12
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
12.6
9.9
17
14
E04.8
ICD-10 Finland
Other specified nontoxic goitre
56.4
9.7
11
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.2
9.4
38
126
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
37.6
9.1
11
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.3
8.8
23
56
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
51.1
8.7
10
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
8.6
26
71
A11CC02
ATC
dihydrotachysterol; oral
28.2
8.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
91.9
8.4
9
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
91.9
8.4
9
*
BAA99
NOMESCO Finland
Other operation on thyroid gland
91.9
8.4
9
*
8339/3-C73.9
ICD-O-3
Follicular carcinoma, encapsulated, angioinvasive of thyroid gland
+∞
8.4
8
*
L02BG03
ATC
anastrozole; oral
+∞
8.4
8
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
8.4
8
*
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
8.4
8
*
JN5AN
NOMESCO Finland
Total body isotope imaging
+∞
8.4
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
7.9
48
199
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.2
7.9
73
366
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.4
7.9
13
10
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
7.7
54
241
JN4CD
NOMESCO Finland
Very extensive body CT
9.1
7.6
15
17
T86
ICPC
Hypothyroidism/myxoedema
3.1
7.4
31
105
A04AA01
ATC
ondansetron; systemic, rectal
4.3
7.4
19
46
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
7.3
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
7.3
7
*
C739, ,
ICD-10 Finland
+∞
7.3
7
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
7.3
7
*
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
+∞
7.3
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
L01EX08
ATC
lenvatinib; oral
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
20.5
7.2
10
5
B01AB05
ATC
enoxaparin; parenteral
1.9
7.1
117
722
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.5
6.9
45
194
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.2
6.6
26
85
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.3
6.6
12
12
A12AA04
ATC
calcium carbonate; oral
10.3
6.6
12
12
XKD00
NOMESCO Finland
Uroflowmetry
2.4
6.5
47
212
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
70.9
6.4
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
70.9
6.4
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.9
6.4
7
*
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
70.9
6.4
7
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
70.9
6.4
7
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.0
6.3
28
98
ZXA00
NOMESCO Finland
Right side
1.8
6.3
107
664
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L01EX02
ATC
sorafenib; oral
+∞
6.3
6
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.9
6.2
16
28
ZXE00
NOMESCO Finland
One hour or less
1.7
6.0
151
1047
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
268
205
37.59
315.37
9.6
3.6
4.60
4.56
pmol/l
0.14
263
181
109
38
39.05
168.91
1.5
1.2
—
—
—
0
0
325
1632
6.29
53.25
13.3
6.0
1.20
1.22
mmol/l
2.57
276
1422
300
1452
5.26
50.28
10.5
5.5
1.21
1.22
mmol/l
1.53
288
1323
113
269
5.46
46.82
2.1
3.8
45.49
81.67
ng/l
12.60
99
237
236
1115
3.72
36.84
5.2
2.0
2.31
2.36
mmol/l
6.77
229
971
90
230
4.76
33.50
6.9
2.7
1.20
1.23
mmol/l
2.99
85
198
45
60
8.32
32.50
2.6
2.6
4.67
9.88
pmol/l
2.21
45
60
65
159
4.69
25.20
3.4
1.6
4.30
2.57
ug/l
0.54
51
121
373
2755
6.24
23.68
14.2
4.4
17.85
14.79
pmol/l
55.24
360
2536
244
1447
2.76
21.43
2.8
2.4
—
—
estimate
—
0
0
231
1425
2.47
17.31
5.4
3.7
36.44
36.22
g/l
0.29
220
1336
249
1613
2.44
16.38
3.0
2.6
80.83
77.96
nmol/l
1.01
235
1447
247
1660
2.28
14.00
7.9
3.7
11.06
11.23
umol/l
0.11
237
1576
329
2522
2.72
13.57
11.6
5.6
76.88
74.98
u/l
0.49
316
2353
36
95
4.07
12.47
2.3
2.4
3.65
5.44
iu/l
0.50
17
44
258
1815
2.19
12.39
9.3
6.3
3.98
4.23
e9/l
1.07
223
1573
270
1988
2.10
10.80
4.9
4.3
6.51
6.66
mmol/l
0.44
257
1873
376
3227
3.75
10.18
19.3
5.5
2.76
1.89
mu/l
0.50
363
2996
42
143
3.16
9.95
1.6
1.4
38.20
28.18
u/ml
0.33
42
138
68
301
2.52
9.88
3.4
3.1
—
—
—
0
0
128
740
2.07
9.82
2.3
1.9
—
—
—
0
0
212
1499
1.88
8.76
14.1
14.2
1.24
1.25
inr
0.16
178
1255
57
261
2.38
7.64
5.2
2.2
238.21
230.68
u/l
0.22
52
247
11
6
18.80
7.64
2.9
1.0
18.27
14.83
u/ml
—
11
6
77
415
2.06
6.91
4.1
4.8
1.07
1.03
mmol/l
0.63
68
369
150
1019
1.76
6.54
4.7
3.7
0.00
0.00
estimate
-0.00
62
345
139
939
1.74
6.10
3.0
2.9
0.39
0.41
e6/l
0.06
107
690
8
5
16.27
5.43
5.4
1.6
86.25
59.60
nmol/l
—
8
5
117
776
1.72
5.38
2.9
2.3
4.40
6.28
e6/l
1.42
104
705
10
12
8.51
5.09
1.9
1.6
12.34
14.99
ug/l
—
10
12
370
3375
2.28
4.73
22.0
13.1
22.38
22.09
mg/l
0.05
314
2695
143
1036
1.59
4.54
4.5
3.1
0.00
0.00
estimate
-0.00
61
295
183
1431
1.51
4.00
5.0
3.5
0.05
0.03
estimate
0.18
59
290
27
119
2.36
3.97
1.8
2.2
9027.20
9686.60
u/l
—
6
50
373
3451
2.20
3.96
22.5
16.1
139.94
139.76
mmol/l
0.76
367
3377
373
3455
2.18
3.88
23.0
16.1
3.93
3.97
mmol/l
2.50
366
3376
177
1382
1.50
3.86
3.9
3.7
24.98
105.60
ng/l
1.02
127
973
230
1902
1.49
3.74
4.9
3.7
0.00
0.02
estimate
0.93
69
351
226
1863
1.49
3.73
4.8
3.6
0.00
0.00
estimate
-0.00
68
360
228
1884
1.49
3.71
4.9
3.7
0.00
0.00
estimate
-0.00
70
367
356
3261
1.83
3.60
22.1
12.4
81.42
80.73
ml/min/173m2
0.25
339
2997
18
70
2.65
3.43
1.7
1.3
74.61
109.54
pmol/l
0.28
18
70
23
101
2.36
3.43
4.0
2.8
25.87
24.77
mmol/l
0.48
23
101
13
38
3.50
3.34
1.2
1.4
—
—
—
0
0
44
258
1.79
3.06
1.3
1.3
73.80
116.86
u/ml
0.75
18
117
20
87
2.37
3.06
4.8
3.4
—
—
—
0
0
19
81
2.41
3.03
4.7
1.3
20.93
1.50
ratio
0.46
12
51
33
180
1.91
2.88
4.5
4.0
2.68
2.13
mmol/l
0.33
26
131
37
210
1.84
2.86
6.0
4.0
5.35
5.16
kpa
0.63
37
203
19
84
2.32
2.82
1.3
1.2
15.97
11.70
u/l
0.25
13
70
138
1093
1.40
2.55
2.4
2.2
108.13
58.18
u/l
1.11
121
1012
5
7
7.22
2.55
1.2
1.0
—
—
—
0
0
54
353
1.61
2.55
5.3
7.1
0.74
1.22
mmol/l
0.52
45
293
67
461
1.54
2.55
2.7
2.3
22.38
22.63
%
0.04
61
432
11
37
3.03
2.50
1.5
1.2
—
—
—
0
0
29
161
1.86
2.42
1.1
1.3
31.77
24.12
iu/l
0.49
24
142
13
53
2.50
2.30
1.1
1.2
—
—
—
0
0
19
93
2.10
2.25
4.8
1.4
37.49
43.75
mg/l
0.32
14
84
19
93
2.10
2.25
4.8
1.4
32.16
30.13
mg/l
0.09
14
82
55
373
1.55
2.24
1.9
2.3
6.89
6.46
umol/l
0.08
47
332
5
9
5.61
2.22
1.2
1.0
—
—
—
0
0
59
410
1.51
2.15
7.9
6.4
—
—
—
0
0
51
345
1.55
2.10
2.2
2.0
405.13
378.86
nmol/l
0.19
46
318
9
31
2.95
2.08
1.1
1.2
—
—
—
0
0
15
69
2.22
2.07
1.5
1.2
—
—
—
0
0
6
16
3.79
1.94
2.5
1.3
0.62
0.93
e9/l
—
6
16
7
22
3.22
1.89
2.0
1.4
—
—
—
0
0
13
59
2.24
1.86
1.4
1.4
—
—
—
0
0
13
59
2.24
1.86
1.4
1.4
—
—
—
0
0
70
520
1.42
1.83
2.2
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
80
2.04
1.82
2.4
2.5
0.29
0.39
iu/ml
—
8
50
7
23
3.08
1.80
1.6
1.3
—
—
—
0
0
12
54
2.26
1.75
1.2
1.2
9.58
17.71
u/l
1.11
12
47
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
8
31
2.61
1.66
1.4
1.2
—
—
—
0
0
5
14
3.60
1.62
1.2
1.4
—
—
—
0
0
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
130
1089
1.29
1.54
3.1
3.3
1132.87
1345.95
ng/l
0.40
112
916
5
15
3.36
1.53
1.2
1.3
15.00
12.87
%
—
5
15
7
27
2.62
1.52
1.1
1.1
114.29
103.74
pmol/l
—
7
27
109
896
1.30
1.49
2.6
2.3
3.59
2.83
mg/l
2.09
96
769
25
156
1.64
1.47
4.6
3.5
1.66
1.59
%
0.27
25
151
7
28
2.53
1.46
1.3
1.0
—
—
—
0
0
37
256
1.49
1.42
3.1
2.1
60.86
68.75
ml/min/173m2
0.61
21
109
13
67
1.97
1.40
1.6
1.2
—
—
—
0
0
7
29
2.44
1.40
1.1
1.1
—
—
—
0
0
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
73
575
1.33
1.35
2.2
2.7
1.32
1.10
e6/l
0.20
41
290
30
434
0.67
1.34
5.3
5.0
31.80
32.14
%
0.06
20
270
279
2588
1.26
1.31
5.1
4.4
12.58
11.36
mm/h
0.59
259
2410
371
3581
1.50
1.29
15.2
9.8
23.88
25.16
u/l
1.12
364
3468
188
1674
1.23
1.28
3.6
3.0
96.47
102.22
ug/l
0.21
177
1563
8
35
2.31
1.27
1.3
1.0
—
—
—
0
0
52
398
1.35
1.18
1.8
1.8
—
—
—
0
0
5
20
2.52
1.15
1.0
1.3
—
—
—
0
0
66
527
1.30
1.12
2.2
2.9
8.63
2.85
e6/l
0.68
34
242
13
73
1.81
1.12
1.4
1.4
—
—
—
0
0
5
21
2.40
1.09
1.6
1.1
—
—
—
0
0
5
21
2.40
1.09
1.6
1.1
—
—
—
0
0
5
21
2.40
1.09
1.6
1.1
—
—
—
0
0
26
369
0.68
1.07
1.6
2.1
3.42
3.42
ratio
0.00
17
299
12
67
1.82
1.05
1.8
1.2
—
—
—
0
0
16
98
1.66
1.05
1.6
1.3
297.77
338.61
ug/g
—
9
58
9
47
1.94
1.02
1.8
1.2
—
—
—
0
0
101
861
1.23
1.01
3.4
2.3
354.59
343.86
umol/l
0.46
87
753
48
373
1.33
1.00
1.9
1.8
—
—
—
0
0
28
199
1.44
0.98
4.8
6.0
24.63
24.77
mmol/l
0.11
28
193
10
54
1.87
0.97
1.2
1.3
—
—
—
0
0
9
50
1.82
0.97
1.3
1.4
—
—
—
0
0
14
85
1.67
0.95
5.9
3.9
1.83
1.58
mg/l
0.50
14
74
20
289
0.68
0.92
1.4
1.9
3.10
3.42
mmol/l
—
10
224
15
94
1.62
0.92
1.5
1.3
—
—
—
0
0
10
56
1.81
0.88
1.5
1.1
—
—
—
0
0
94
812
1.21
0.83
5.7
4.1
2.30
1.87
ug/l
0.66
84
737
26
190
1.39
0.81
1.3
1.4
—
—
—
0
0
99
864
1.19
0.78
5.5
3.6
1.02
1.02
kg/l
0.24
66
571
378
3702
1.38
0.74
34.5
20.1
252.58
250.75
e9/l
0.23
373
3639
7
40
1.76
0.71
1.4
2.0
17.19
97.57
u/ml
—
7
40
378
3704
1.37
0.71
34.4
20.1
4.52
4.50
e12/l
0.42
372
3632
10
61
1.66
0.69
1.2
1.3
277.20
202.77
u/ml
—
5
31
9
59
1.54
0.69
1.9
1.2
—
—
—
0
0
5
30
1.67
0.61
3.8
1.6
623.20
788.97
mg
—
5
30
56
476
1.21
0.60
2.7
1.8
29.46
29.31
s
0.05
56
463
244
2319
1.13
0.58
3.9
3.1
43.67
41.19
u/l
0.23
223
2183
6
36
1.68
0.57
3.3
2.4
13.33
13.37
%
—
6
36
10
65
1.55
0.56
1.3
1.6
—
—
—
0
0
41
341
1.23
0.55
2.5
3.2
2.20
1.79
mmol/l
0.39
33
293
35
423
0.81
0.53
2.3
2.1
—
—
—
0
0
31
379
0.80
0.53
2.2
2.0
—
—
—
0
0
75
664
1.16
0.52
1.5
1.6
—
—
—
0
0
13
92
1.43
0.51
1.4
1.2
—
—
—
0
0
16
118
1.37
0.51
6.6
4.7
26.17
25.05
mmol/l
0.53
16
110
27
216
1.27
0.51
1.9
1.5
—
—
—
0
0
17
128
1.34
0.48
1.1
1.2
0.89
0.87
g/l
0.20
17
128
53
464
1.16
0.43
4.1
2.8
0.71
0.75
ug/l
0.15
35
289
82
742
1.13
0.43
1.8
1.7
504.34
6472932.15
pmol/l
0.50
70
618
0
16
0.00
0.41
0.0
1.8
—
37.56
—
0
16
114
1055
1.11
0.41
1.8
1.6
20.09
20.47
nmol/l
0.10
106
899
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
72
649
1.13
0.40
4.7
3.8
19.48
24.30
%
2.67
37
289
7
104
0.67
0.40
1.1
1.2
594.00
435.65
mg/l
—
7
96
8
61
1.32
0.39
1.0
1.8
—
—
—
0
0
17
133
1.29
0.39
2.6
2.4
32.55
40.45
u/l
0.80
11
119
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
16
126
1.28
0.35
1.0
1.1
1.37
1.58
g/l
3.58
16
126
35
302
1.17
0.35
2.1
2.5
4.91
6.38
ug/l
0.36
28
262
13
100
1.31
0.34
1.4
1.2
—
—
—
0
0
62
681
0.89
0.32
4.2
4.0
257.56
392.35
ng/l
0.22
52
527
15
121
1.25
0.29
1.4
1.3
1.58
14.10
u/ml
—
6
25
8
64
1.26
0.27
1.8
1.3
—
—
—
0
0
11
86
1.29
0.26
1.5
1.5
19793.67
18005.69
e6/l
—
6
55
35
390
0.89
0.24
2.1
1.7
1.54
1.39
%
0.33
30
345
116
1218
0.93
0.23
4.8
4.0
14.96
7.17
mg/mmol
0.69
67
738
7
92
0.76
0.22
1.1
1.2
3.99
3.82
mmol/l
—
7
85
7
95
0.73
0.22
1.1
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
348.00
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
16
187
0.85
0.20
2.4
1.7
—
—
—
0
0
122
1273
0.94
0.20
3.7
3.2
7.43
7.53
mmol/l
0.10
109
1077
6
49
1.23
0.20
1.2
1.6
—
—
—
0
0
338
3338
1.08
0.19
5.1
5.1
5.85
5.93
mmol/l
0.62
315
3073
84
886
0.93
0.19
1.4
1.3
1.84
1.35
u/ml
0.27
29
255
6
52
1.16
0.19
2.5
1.3
0.48
0.59
nmol/l
—
6
46
35
320
1.10
0.18
2.5
2.1
34.33
35.90
u/l
0.10
30
262
7
63
1.11
0.17
1.1
1.7
—
—
—
0
0
156
1608
0.95
0.17
2.1
2.1
96.39
98.38
pmol/l
0.23
86
811
18
158
1.15
0.16
1.7
2.1
5.17
6.27
iu/ml
—
7
41
8
71
1.13
0.16
1.3
1.3
—
—
—
0
0
10
83
1.21
0.15
1.2
1.3
—
—
—
0
0
64
606
1.07
0.15
1.3
1.5
—
—
—
0
0
336
3393
0.94
0.15
5.0
5.1
1.45
1.50
mmol/l
1.53
316
3161
149
1532
0.96
0.14
2.2
1.9
1.41
1.33
mmol/l
0.67
124
1315
11
94
1.18
0.13
2.6
2.4
38.33
92.91
ug/min
—
6
57
9
107
0.84
0.13
5.0
1.5
—
—
—
0
0
320
3231
0.95
0.12
4.2
4.3
1.33
1.27
mmol/l
1.02
298
2980
323
3256
0.96
0.10
6.6
6.5
38.98
39.21
mmol/mol
0.20
301
3058
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
26
278
0.93
0.09
1.5
1.4
—
—
—
0
0
58
603
0.96
0.09
2.3
1.7
1412.09
1220.76
nmol/l
0.62
47
459
10
113
0.88
0.08
5.2
1.6
—
—
—
0
0
339
3411
0.96
0.08
5.2
5.2
4.62
4.64
mmol/l
0.14
320
3194
7
66
1.06
0.08
1.1
1.7
—
—
—
0
0
6
73
0.82
0.07
1.0
1.6
1.34
0.88
nmol/l
—
6
57
20
186
1.08
0.07
1.1
1.1
—
—
—
0
0
10
111
0.90
0.06
2.8
3.8
1.35
1.32
mmol/l
—
10
106
347
3455
1.03
0.05
5.8
5.9
2.74
2.70
mmol/l
0.39
326
3231
10
110
0.91
0.05
1.5
1.1
—
—
—
0
0
77
786
0.97
0.05
1.5
1.6
0.74
1.10
mg/l
1.72
62
603
10
109
0.92
0.04
1.5
1.1
—
—
—
0
0
18
190
0.94
0.04
1.4
1.4
—
—
—
0
0
66
673
0.98
0.03
1.5
1.3
16.90
11.50
u/ml
0.21
30
256
213
2144
0.99
0.03
3.6
3.2
—
—
—
0
0
18
189
0.95
0.03
1.9
2.5
1.00
1.17
%
0.80
18
189
72
729
0.98
0.02
1.5
1.4
15.69
35.90
iu/ml
3.90
26
219
12
127
0.94
0.01
1.1
1.6
—
—
—
0
0
19
197
0.96
0.01
1.8
1.9
—
—
—
0
0
23
237
0.97
0.01
2.0
2.0
—
—
—
0
0
28
274
1.02
0.00
5.1
5.6
10.60
9.55
mmol/l
0.26
23
260
12
118
1.02
0.00
2.2
1.7
—
—
—
0
0
13
128
1.02
0.00
1.5
1.5
—
—
—
0
0
13
129
1.01
0.00
1.7
1.7
—
—
—
0
0
18
185
0.97
0.00
1.9
2.4
0.64
0.60
%
0.20
18
185
6
64
0.94
0.00
1.2
1.2
—
24.20
—
0
5
0
7
0.00
-0.00
0.0
2.6
—
134.14
—
0
7
0
8
0.00
-0.00
0.0
3.6
—
4.54
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.6
—
10.34
—
0
8
0
9
0.00
-0.00
0.0
1.1
—
106.22
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
0.54
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
24
240
1.00
-0.00
1.3
1.4
—
42.85
—
0
21
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_FOLLICULAR_WIDE – Follicular adenocarcinoma of thyroid gland, including Hilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).